Credicorp Ltd. (NYSE:BAP) is Genesis Investment Management LLP’s 2nd Largest Position

Genesis Investment Management LLP reduced its position in shares of Credicorp Ltd. (NYSE:BAPFree Report) by 79.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 73,044 shares of the bank’s stock after selling 280,391 shares during the quarter. Credicorp comprises about 14.7% of Genesis Investment Management LLP’s portfolio, making the stock its 2nd biggest position. Genesis Investment Management LLP owned 0.09% of Credicorp worth $13,390,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its position in shares of Credicorp by 37.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 226 shares of the bank’s stock worth $41,000 after purchasing an additional 62 shares during the period. Brown Brothers Harriman & Co. bought a new stake in Credicorp during the 3rd quarter valued at $58,000. Aprio Wealth Management LLC purchased a new position in shares of Credicorp in the 4th quarter valued at $200,000. Dynamic Advisor Solutions LLC bought a new position in shares of Credicorp in the 3rd quarter worth $216,000. Finally, Sanctuary Advisors LLC purchased a new stake in shares of Credicorp during the 2nd quarter worth $210,000. 89.81% of the stock is owned by institutional investors.

Credicorp Price Performance

Shares of BAP stock opened at $181.80 on Tuesday. Credicorp Ltd. has a fifty-two week low of $146.05 and a fifty-two week high of $200.00. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $14.46 billion, a price-to-earnings ratio of 10.43, a PEG ratio of 0.48 and a beta of 1.12. The stock’s 50-day simple moving average is $187.42 and its 200-day simple moving average is $179.70.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. JPMorgan Chase & Co. lifted their target price on Credicorp from $200.00 to $219.00 and gave the company an “overweight” rating in a research note on Tuesday, November 12th. Bank of America lowered shares of Credicorp from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $209.00 to $208.00 in a research note on Monday, December 16th. Finally, The Goldman Sachs Group increased their target price on shares of Credicorp from $143.00 to $160.00 and gave the company a “sell” rating in a research report on Tuesday, October 8th.

View Our Latest Analysis on BAP

About Credicorp

(Free Report)

Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.

Featured Stories

Institutional Ownership by Quarter for Credicorp (NYSE:BAP)

Receive News & Ratings for Credicorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credicorp and related companies with MarketBeat.com's FREE daily email newsletter.